Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03669718
Title A Randomized Phase 2 Study of Cemiplimab +/- ISA101b in HPV16-Positive OPC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ISA Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | HUN | GBR | FRA | ESP | DEU | CZE | BRA | BEL


No variant requirements are available.